Surgery vs. chemotherapy for ovarian cancer recurrence: what is the best treatment option

Vito Andrea Capozzi, Andrea Rosati, Luigi Carlo Turco, Giulio Sozzi, Matteo Riccò, Benito Chiofalo, Giuseppe Vizzielli

Research output: Contribution to journalReview articlepeer-review


Nowadays, the best treatment option for ovarian cancer recurrence is often subjective, can vary in the different centers and depend on personal experience. Arbeitsgemeinschaft Gynaekologische Onkologie (AGO)-DESKTOP studies have identified a population of patients who could benefit from secondary surgery. The results of the Gynecologic Oncology Group (GOG)-0213 study were recently published, which showed no advantage in terms of overall survival (OS) in patients with platinum-sensitive recurrent epithelial ovarian undergoing secondary cytoreductive surgery (SCS) compared to chemotherapy alone. Aim of this narrative review is to summarize the best aspects that can make ovarian cancer recurrence patients suitable for SCS. A narrative review analyzing all the literature of the past 30 years has been performed. PubMed, Scopus, Web of Science and Ovid MEDLINE were used for research. All non-English-language articles have been excluded. The following keywords were searched: 'recurrent ovarian cancer', 'secondary surgery', 'secondary cytoreductive surgery', 'platinum-sensitive ovarian cancer', 'platinum-resistant ovarian cancer'. We divided eligible patients for secondary cytoreduction in relation to the following factors: platinum-sensitivity, AGO-score or Tian model, unresectable lesions, surgical generic contraindication, woman's personal choice. The selection of truly suitable patients for surgery seems an essential requirement for the patient's best therapeutic choice. In case of absent post-surgical residual tumor, good performance status, single recurrence, and platinum-sensitive ovarian recurrence, surgery could be performed.

Original languageEnglish
Pages (from-to)1112-1117
Number of pages6
JournalGland Surgery
Issue number4
Publication statusPublished - Aug 2020


Dive into the research topics of 'Surgery vs. chemotherapy for ovarian cancer recurrence: what is the best treatment option'. Together they form a unique fingerprint.

Cite this